Cargando…

Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer

At initial diagnosis, most patients with small-cell lung cancer (SCLC) present with metastatic disease with a high number of tumor cells (CTCs) circulating in the blood. We analyzed RNA transcripts specific for neuroendocrine and for epithelial cell lineages, and Notch pathway delta-like 3 ligand (D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obermayr, Eva, Agreiter, Christiane, Schuster, Eva, Fabikan, Hannah, Weinlinger, Christoph, Baluchova, Katarina, Hamilton, Gerhard, Hochmair, Maximilian, Zeillinger, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721820/ https://www.ncbi.nlm.nih.gov/pubmed/31412616 http://dx.doi.org/10.3390/cells8080880

Ejemplares similares

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2021)

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
por: Sajdik, Constantin, et al.
Publicado: (2022)

Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
por: Obermayr, Eva, et al.
Publicado: (2017)

Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
por: Hochmair, Maximilian, et al.
Publicado: (2019)

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
por: Welsch, Eva, et al.
Publicado: (2023)

Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2019)

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
por: Illini, Oliver, et al.
Publicado: (2022)

Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer
por: Hamilton, Gerhard, et al.
Publicado: (2015)

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
por: Plangger, Adelina, et al.
Publicado: (2021)

Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study
por: Maritschnegg, Elisabeth, et al.
Publicado: (2018)

Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells
por: STICKLER, SANDRA, et al.
Publicado: (2023)

Microfluidic enrichment for the single cell analysis of circulating tumor cells
por: Yeo, Trifanny, et al.
Publicado: (2016)

Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
por: Rath, Barbara, et al.
Publicado: (2023)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance
por: Klameth, Lukas, et al.
Publicado: (2017)

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis
por: Hochmair, Maximilian J., et al.
Publicado: (2020)

Effectiveness of Outpatient Pulmonary Rehabilitation in Patients with Surgically Resected Lung Cancer: A Retrospective Real-World Analysis
por: Illini, Oliver, et al.
Publicado: (2022)

Automated Microfluidic Blood Lysis Protocol for Enrichment of Circulating Nucleated Cells
por: White, William N., et al.
Publicado: (2009)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
por: Obermayr, Eva, et al.
Publicado: (2010)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Cancer cell enrichment on a centrifugal microfluidic platform using hydrodynamic and magnetophoretic techniques
por: Shamloo, Amir, et al.
Publicado: (2021)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
por: Hackner, Klaus, et al.
Publicado: (2021)

Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization
por: Cohen, Evan N., et al.
Publicado: (2020)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells
por: Plangger, Adelina, et al.
Publicado: (2021)

Stiffness based enrichment of leukemia cells using microfluidics
por: Islam, Muhymin, et al.
Publicado: (2020)

Recent Advances in Microfluidic Platform for Physical and Immunological Detection and Capture of Circulating Tumor Cells
por: Bhat, Mahesh Padmalaya, et al.
Publicado: (2022)

An Automatic Platform Based on Nanostructured Microfluidic Chip for Isolating and Identification of Circulating Tumor Cells
por: Jou, Hei-Jen, et al.
Publicado: (2021)

AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells
por: Deliorman, Muhammedin, et al.
Publicado: (2020)

Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells
por: Khoo, Bee Luan, et al.
Publicado: (2014)

Integrated Microfluidic Device for Enrichment and Identification of Circulating Tumor Cells from the Blood of Patients with Colorectal Cancer
por: Su, Wentao, et al.
Publicado: (2019)

Design and Fabrication of a Novel Microfluidic System for Enrichment of Circulating Tumor Cells with the Assistance of Computer Simulations
por: Dorrigiv, Dina, et al.
Publicado: (2019)

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood
por: Rodríguez‐Pena, Alejandro, et al.
Publicado: (2022)

Analytical Validation of a Spiral Microfluidic Chip with Hydrofoil-Shaped Pillars for the Enrichment of Circulating Tumor Cells
por: Sen-Dogan, Begum, et al.
Publicado: (2023)

Correction: Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells
Publicado: (2014)

Circulating tumour cell RNA characterisation from colorectal cancer patient blood after inertial microfluidic enrichment
por: Winter, Marnie, et al.
Publicado: (2019)

Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device
por: Montoya Mira, Jose, et al.
Publicado: (2021)

Development of cell metabolite analysis on microfluidic platform()
por: Lin, Luyao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hl4cun8v0hmhmq9ol8g4gksoud